Quick Takeaways
- David E. Lazar filed SCHEDULE 13G for Matinas BioPharma Holdings, Inc. Common Stock, par value $0.0001 per share (MTNB).
- Disclosed ownership: 9.8%.
- Date of event: 15 Aug 2025.
David E. Lazar - 15 Aug 2025 SCHEDULE 13G Report for Matinas BioPharma Holdings, Inc. Common Stock, par value $0.0001 per share (MTNB)
- Filing Manager
- David E. Lazar
- Reporting Manager
- Lazar David E.
- Symbol
- MTNB
- Shares outstanding
- 5,555,556 shares
- Disclosed Ownership
- 545,000 shares
- Ownership
- 9.8%
- Form type
- SCHEDULE 13G
- Filing time
- 19 Aug 2025, 12:03:02 UTC
- Date of event
- 15 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"David E. Lazar disclosed 9.8% ownership in Matinas BioPharma Holdings, Inc. Common Stock, par value $0.0001 per share (MTNB) on 15 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 Aug 2025, 12:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lazar David E. | 9.8% | 545,000 | 0 | 545,000 | /s/ David E. Lazar | David E. Lazar |